Breaking News Instant updates and real-time market news.

AKAO

Achaogen

$7.00

0.13 (1.89%)

07:42
08/07/18
08/07
07:42
08/07/18
07:42

Achaogen downgraded to Hold at Needham on drug program risk

As noted earlier, Needham anayst Alan Carr downgraded Achaogen to Hold from Buy after its quarterly update, saying that while he sees the company's Zemdri antibiotic to be most relevant in the CRE market, he sees it as "modest in size and at high risk of becoming crowded". Carr adds that the other potential major product for the company such as C-Scape is at higher risk with a longer commercialization time frame then previously expected. The analyst also notes Achaogen's cash position of $100.5M, which is only sufficient to sustain operations through Q1 of 2019.

  • 14

    Aug

  • 30

    Aug

  • 31

    Aug

AKAO Achaogen
$7.00

0.13 (1.89%)

06/27/18
HCWC
06/27/18
NO CHANGE
Target $19
HCWC
Buy
Achaogen selloff following FDA approval excessive, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce attributes the pullback in Achaogen shares after the company announced yesterday the FDA approval of Zemdri for cUTI to disappointment that the FDA did not also approve plazomicin for CRE infections via a bloodstream infections indication. However, while he believes a BSI indication would have been helpful, he thinks it is "by no means necessary" to successfully market Zemdri for CRE and he calls yesterday's selloff "excessive." Arce affirms a Buy rating on Achaogen shares with a $19 price target.
07/13/18
WBLR
07/13/18
NO CHANGE
WBLR
Outperform
Achaogen 30% pullback since last month overdone, says William Blair
After attending the company's investor event, William Blair analyst Y. Katherine Xu says shares of Achaogen at current levels offer an attractive entry opportunity. While most of the Street has modeled the use of Zemdri in carbapenem-resistant enterobacteriaceae, extended-spectrum beta-lactamases-producing bacteria is also a major target and represents a much larger population, Xu tells investors in a research note. Further, she believes physicians are and will be comfortable to use Zemdri off-label in blood stream infections and pneumonia. The analyst views the 30% pullback in Achaogen shares since the complicated urinary tract infections approval last month as overdone and thinks her $23 fair value estimate could prove conservative. Xu keeps an Outperform rating on Achaogen.
08/03/18
08/03/18
NO CHANGE

Achaogen's Zemdri granted NTAP status by the CMS
Achaogen announced that the Centers for Medicare & Medicaid Services - CMS - has granted a new technology add-on payment, or NTAP, for Zemdri when administered in the hospital inpatient setting. The NTAP program will provide hospitals with a payment, in addition to the standard-of-care Diagnostic Related Group reimbursement, of up to 50% of the cost of Zemdr ifor a period of two to three years, effective in the 2019 fiscal year starting on October 1, 2018. CMS has assigned a maximum payment of $2,722.50 for a patient treated with ZEMDRI.
08/07/18
NEED
08/07/18
DOWNGRADE
NEED
Hold
Achaogen downgraded to Hold from Buy at Needham

TODAY'S FREE FLY STORIES

AMC

AMC Entertainment

$15.49

0.3 (1.98%)

15:08
11/13/18
11/13
15:08
11/13/18
15:08
Recommendations
AMC Entertainment analyst commentary  »

AMC seeing success with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 04

    Dec

AAWW

Atlas Air

$55.19

2.03 (3.82%)

15:05
11/13/18
11/13
15:05
11/13/18
15:05
Hot Stocks
Atlas Air, Southern Air announce pathway program agreement with Ameriflight »

Atlas Air Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$90.46

1.99 (2.25%)

15:04
11/13/18
11/13
15:04
11/13/18
15:04
Options
Wix.com options imply 18.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

ECA

Encana

$8.10

-0.31 (-3.69%)

15:00
11/13/18
11/13
15:00
11/13/18
15:00
Options
Encana option volume hits year high as shares touch year lows »

Encana option volume hits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

, AAPL

Apple

$193.43

-0.725 (-0.37%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple, Lumentum, Skyworks, Cirrus Logic, Broadcom analyst commentary  »

After Qorvo warns, MKM…

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

AAPL

Apple

$193.43

-0.725 (-0.37%)

LITE

Lumentum

$38.92

1.415 (3.77%)

SWKS

Skyworks

$72.16

-0.61 (-0.84%)

CRUS

Cirrus Logic

$37.63

1.99 (5.58%)

AVGO

Broadcom

$224.39

0.84 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

  • 06

    Dec

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

, AAPL

Apple

$193.50

-0.655 (-0.34%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple analyst commentary  »

JPMorgan sees…

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

AAPL

Apple

$193.50

-0.655 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

AMRS

Amyris

$6.05

0.19 (3.24%)

14:49
11/13/18
11/13
14:49
11/13/18
14:49
Options
Amyris options imply 19.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BA

Boeing

$347.91

-9.02 (-2.53%)

14:46
11/13/18
11/13
14:46
11/13/18
14:46
Periodicals
Pilots claim Boeing Lion Air crash linked to improper training, FT reports »

Pilot associations said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$193.31

-0.845 (-0.44%)

14:45
11/13/18
11/13
14:45
11/13/18
14:45
Technical Analysis
Technical Take: Apple moves lower after rally fails »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

XLK

Technology Select Sector SPDR

$67.49

0.08 (0.12%)

14:40
11/13/18
11/13
14:40
11/13/18
14:40
Options
Aggressive call buying in SPDR Tech Fund »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

, AAPL

Apple

$192.80

-1.355 (-0.70%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Qorvo, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

AAPL

Apple

$192.80

-1.355 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

, IPAS

iPass

$1.14

(0.00%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Pareteum, iPass analyst commentary  »

Pareteum price target…

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

IPAS

iPass

$1.14

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

CF

CF Industries

$50.26

-1.03 (-2.01%)

14:35
11/13/18
11/13
14:35
11/13/18
14:35
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LVS

Las Vegas Sands

$51.96

0.995 (1.95%)

14:25
11/13/18
11/13
14:25
11/13/18
14:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
11/13/18
11/13
14:25
11/13/18
14:25
General news
Treasury Action: yields remained remained lower »

Treasury Action: yields…

VOYA

Voya Financial

$45.49

0.905 (2.03%)

14:24
11/13/18
11/13
14:24
11/13/18
14:24
Recommendations
Voya Financial analyst commentary  »

Voya Financial updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/13/18
11/13
14:17
11/13/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLDP

Ballard Power

$3.07

0.11 (3.72%)

14:16
11/13/18
11/13
14:16
11/13/18
14:16
Hot Stocks
Ballard Power announces closing of strategic collaboration with Weichai Power »

Ballard Power Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/13/18
11/13
14:16
11/13/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
11/13/18
11/13
14:15
11/13/18
14:15
General news
U.S. Treasury budget deficit widened to $100 B »

U.S. Treasury budget…

APTI

Apptio

$37.76

0.12 (0.32%)

14:10
11/13/18
11/13
14:10
11/13/18
14:10
Options
Aptio attracts call buying after reports of takeover interest »

Aptio attracts call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

14:10
11/13/18
11/13
14:10
11/13/18
14:10
General news
U.S. Treasury budget preview: »

U.S. Treasury budget…

BAIRY

British Airways

$0.00

(0.00%)

, ICAGY

IAG

$0.00

(0.00%)

14:10
11/13/18
11/13
14:10
11/13/18
14:10
Hot Stocks
British Airways, Iberia Airlines to pay $5.8M to settle False Claims Act charges »

The Justice Department…

BAIRY

British Airways

$0.00

(0.00%)

ICAGY

IAG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$31.45

0.17 (0.54%)

, TRCO

Tribune Media

$38.90

-0.455 (-1.16%)

14:09
11/13/18
11/13
14:09
11/13/18
14:09
Hot Stocks
DOJ confirms settlement with Sinclair, Tribune, Meredith, others »

The Department of Justice…

SBGI

Sinclair Broadcast

$31.45

0.17 (0.54%)

TRCO

Tribune Media

$38.90

-0.455 (-1.16%)

MDP

Meredith

$57.04

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

OAS

Oasis Petroleum

$8.43

-0.33 (-3.77%)

14:05
11/13/18
11/13
14:05
11/13/18
14:05
Options
Oasis Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.